Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04081623 · ClinicalTrials.gov registry record
Trans-abdominal Fetal Pulse Oximetry: Signal Integrity
A clinical trial, sponsored by Raydiant Oximetry.
- Terminated
- Registry status
- 9
- Enrollment target
NCT04081623: Clinical Trial study, sponsored by Raydiant Oximetry.
NCT04081623 is a clinical trial that was terminated before completion, run by Raydiant Oximetry. The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04081623 was terminated before completion, sponsored by Raydiant Oximetry.
- TERMINATED
- Registry status
- 9 participants
- Enrollment target
Study Summary
This project is set up to advance and integrate the established mathematical principles of oxygen saturation to model with increasing accuracy the "body in a body" problem of fetus in mother; similar to existing pulse oximeters,
Primary Outcome
Integrity of the fetal signal relative to background maternal signal and biologic/electronic noise, and related to fetal position, presentation and the depth of the fetus from maternal skin.
Interventions
- DEVICE Raydiant Oximetry Sensing System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2019-04-16 |
| Est. Completion | 2021-06-08 |
Why NCT04081623 stopped before completion
NCT04081623 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 9 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Raydiant Oximetry Sensing System is the first listed.
NCT04081623 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04081623 about?
NCT04081623 is a clinical study titled "Trans-abdominal Fetal Pulse Oximetry: Signal Integrity". This project is set up to advance and integrate the established mathematical principles of oxygen saturation to model with increasing accuracy the "body in a body" problem of fetus in mother; similar to existing pulse oximeters,
What is the current status of trial NCT04081623?
This trial is currently terminated. The enrollment target is 9 participants. The study started on 2019-04-16. Estimated completion is 2021-06-08.
What interventions are being tested in trial NCT04081623?
The interventions under investigation include: Raydiant Oximetry Sensing System (DEVICE).
Who is sponsoring clinical trial NCT04081623?
This trial is sponsored by Raydiant Oximetry, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI